NMNAT3 is protective against the effects of neonatal cerebral hypoxia-ischemia
These drugs work by mimicking the action of the naturally occurring hormone GLP-1, which is released from the gut after eating
doi: 10.1038/s41588-025-02295-y 142
In general, and similar to FDA-approved labeling for GLP-1 weight-management medications, you may be considered for a GLP-1 prescription if you: Have a BMI of 30 or higher (obesity), or Have a BMI between 2729.9 (overweight) plus a weight-related health condition Weight-related conditions can include high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, or PCOS (Polycystic Ovary Syndrome), for example
BPC-157, however, was reported to significantly improve recovery of rat Achilles tendons, helping restore both function and structure [5]